The Hunk Alert

Recent news on MSLP, RELV, and MJN

crwefinancelogo2

signup3m

MusclePharm Corporation (OTC:MSLP), one of the nations fastest growing nutritional supplement companies has recently reported a distribution agreement with Sportika Export Inc. a leading sports nutrition distributor to over 130 couontries. MusclePharms products are currently available in 1,200 of the top GNC stores in the United States, as well as over 450 Vitamin Shoppe stores. MusclePharm’s award-winning products Assault, Battle Fuel, Bullet Proof, Combat Powder, Recon and Shred Matrixare also available online at gnc.com, bodybuilding.com, amazon.com and many other locations.

Brad Pryatt CEO of MusclePharm stated that The company is very excited about the opportunity to expand distribution into over 130 markets as we continue to grow MusclePharm’s international brand presence and creating a strategic partnership with Sportika Export will allow us to broaden our nutritional product formulations availability in the global healthy living and wellness industry as we strive to increase sales and profitability long-term.

MSLP is a fast-growing developer and manufacturer of safe, scientifically approved nutritional supplements that are free of banned substances and tested by athletes. They are designed to help athletes, bodybuilders, weightlifters and fitness enthusiasts improve their performance. Each and every MusclePharm product is the end result of an advanced six-stage research and testing protocol involving the expertise of top nutrition scientists.

Reliv International, Inc. (Nasdaq:RELV) is a developer, manufacturer and marketer of a proprietary line of nutritional supplements. Reliv supplements address essential daily nutrition, weight loss and targeted solutions such as energy and performance enhancement, digestive health, women’s health and anti-aging. Reliv sells its products through an international network marketing system of approximately 64,000 independent distributors.

Reliv International, Inc. a nutritionand direct selling company, recently reported consolidated net sales of $18.8 million for the second quarter
of 2010, compared to net sales of $20.1 million in the second quarter of last year. International sales rose 18.7 percent compared to the same quarter in 2009, but U.S. sales were down 9.5 percent in the quarter.

Net income was $206,000 compared to net income of $410,000 in the second quarter of last year. Diluted earnings per share totaled $0.02 in the second quarter this year compared to $0.03 in the same quarter last year.

U.S. sales for the quarter totaled approximately $15.9 million compared to $17.6 million in the second quarter of 2009. Sales outside of the U.S. rose to approximately $2.9 million compared to net sales of approximately $2.4 million in last year’s second quarter. In local currencies,international sales rose 11.3 percent in the second quarter compared to the same quarter last year. Sales outside of the U.S. account for 15 percent of net sales.

Mead Johnson Nutrition Company (NYSE:MJN) recently reported that the company has extended their supply agreement with Martek Biosciences Corporation for DHA (docosahexaenoic acid) and ARA (arachidonic acid) for use in its infant formula products. Mead Johnson will continue to be supplied with DHA and ARA from Martek for all of its infant formula products until December 2015. Under the terms of the amended agreement, Martek will provide graduated price reductions to Mead Johnson over the time period of the extension, beginning in 2010. In addition, Mead Johnson has the option to add another four years to the extension beyond 2015. Mead Johnson said that estimated cost reductions for 2010 would not be material and would not affect its previously announced annual earnings guidance.

MJN a global leader in pediatric nutrition, develops, manufactures, markets and distributes more than 70 products in 60 markets worldwide. The company’s mission is to create nutritional brands and products trusted to give infants and children the best start in life. The Mead Johnson name has been associated with science-based pediatric nutrition products for over 100 years. The company’s Enfa family of brands, including Enfamil® infant formula, is the world’s leading brand franchise in pediatric nutrition.

http://crwefinance.com/img/crwefinance_new_buscard2.jpg

Signup for FREE Daily Stock Alerts From CRWEFinance.com/signup

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (read more ) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) has received twenty five thousand dollars in cash and seventy five thousand free trading shares from a third party (Bishop Equity Partners) for (30) days of advertising for Muscle Pharm Corp. (MSLP.OB).

About the Author

VOTE MHP FOR THE 2010 BODYBUILDING.COM SUPPLEMENT AWARDS